Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

A Prats-Uribe, AG Sena, LYH Lai, H Alghoul, O Alser… - bmj, 2021 - bmj.com
Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …

[HTML][HTML] Thirty-day outcomes of children and adolescents with COVID-19: an international experience

…, A Pistillo, P Casajust, AG Sena, LYH Lai… - …, 2021 - publications.aap.org
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …

[HTML][HTML] Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a …

EA Voss, A Shoaibi, LYH Lai, C Blacketer… - …, 2023 - thelancet.com
Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …

[HTML][HTML] Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France …

…, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai… - Medrxiv, 2020 - ncbi.nlm.nih.gov
Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments,
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…

[HTML][HTML] Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom

…, A Golozar, M Gong, LYH Lai… - International Journal of …, 2021 - nature.com
Background A detailed characterization of patients with COVID-19 living with obesity has
not yet been undertaken. We aimed to describe and compare the demographics, medical …

CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention

M Mejin, WN Tiong, LYH Lai, LL Tiong… - International Journal of …, 2013 - Springer
Background Cytochrome P450 2C19 (CYP2C19) loss-of-function polymorphisms are more
common in Asian populations and have been associated with diminished antiplatelet …

Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta …

LYH Lai, E Harris, RM West, SL Mackie - RMD open, 2018 - rmdopen.bmj.com
Background Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are almost always
treated with glucocorticoids (GCs), but long-term GC use is associated with diabetes mellitus …

Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal …

LYH Lai, A Golozar, A Sena, AV Margulis, N Haro… - medRxiv, 2020 - medrxiv.org
OBJECTIVES To describe comorbidities, symptoms at presentation, medication use, and 30-day
outcomes after a diagnosis of COVID-19 in pregnant women, in comparison to pregnant …

[HTML][HTML] Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States

…, JD Posada, NH Shah, J Jonnagaddala, LYH Lai… - medRxiv, 2021 - ncbi.nlm.nih.gov
… Shah, 29 Jitendra Jonnagaddala, 30 Lana Yin Hui Lai, 31 Francesc Xavier Avilés-Jurado,
32, 33 George Hripcsak, 5 Marc A. Suchard, 34 Otavio T. Ranzani, 35, 36 Patrick Ryan, 3 …

Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom

…, S Fernandez-Bertolin, A Golozar, M Gong, LYH Lai… - medRxiv, 2020 - medrxiv.org
Background COVID-19 may differentially impact people with obesity. We aimed to describe
and compare the demographics, comorbidities, and outcomes of obese patients with COVID-…